Bioengineer.org news story
For people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure.
A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years. The sheer scale of the cohort allowed the team to examine blip incidence across different drug classes with unusual statistical precision.
Read the full news story here.
Source : Bioengineer.org
Related HIV and Co-Infections News
-
Bioengineer.org | Archived HIV resistance mutation surfaced years later to undermine long-acting therapy
-
LSHTM | Six injections a year instead of 365 pills: Can long-acting HIV treatment change care in Africa?
-
[IDWeek 2026] Infectious Disease Advisor | Bictegravir/lenacapavir well tolerated in people with HIV and comorbidities
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.